Exelixis Announces Results from the Dose-Escalation Stage of the Phase 1b COSMIC-021 Study of Cabozantinib in …

Spread the love

  1. Exelixis Announces Results from the Dose-Escalation Stage of the Phase 1b COSMIC-021 Study of Cabozantinib in … Associated Press (press release) (blog)
  2. Full coverage

…read more

Source:: Alameda, California News By Google News

Start a Conversation

[ghozylab-instagram feed=26796]